IP Library Granted Patent US 7,799,808
Granted Patent B2
US 7,799,808 · App. 11/765,397 · Granted Sep 21, 2010

α-Haloketone derivatives of imidazolyl-substituted aromatic compounds and compounds prepared therefrom

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,799,808
App. No.
11/765,397
Granted
Sep 21, 2010
Kind
B2
Abstract

Novel compounds, compositions, and kits are provided. Methods of modulating Aβ levels, and methods of treating a disease associated with aberrant Aβ levels are also provided.

Claims (43)

1. A compound having a structure corresponding to Formula (I):

A-B-C(O)—CR 2 —X  (I)

wherein A is:

wherein each E is independently CR 1 ; and

each R 1 is independently hydrogen, halogen, substituted or unsubstituted alkyl, substituted or unsubstituted alkenyl, substituted or unsubstituted alkynyl, substituted or unsubstituted alkoxy, substituted or unsubstituted alkylamido, substituted or unsubstituted alkylamino, substituted or unsubstituted amino, substituted or unsubstituted cycloalkyl, or substituted or unsubstituted aryl;

B is

wherein each G is independently CR 2 or N, provided that one or two G′ s are N; and

wherein each R 2 is independently selected from hydrogen, halogen, substituted or unsubstituted alkyl, substituted or unsubstituted alkenyl, substituted or unsubstituted alkynyl, substituted or unsubstituted alkoxy, substituted or unsubstituted alkylamido, substituted or unsubstituted alkylamino, substituted or unsubstituted amino;

each R is independently hydrogen, substituted or unsubstituted alkyl, substituted or unsubstituted alkenyl, substituted or unsubstituted alkynyl, substituted or unsubstituted alkoxy, substituted or unsubstituted alkylamido, substituted or unsubstituted alkylamino, substituted or unsubstituted cycloalkyl, or substituted or unsubstituted aryl; and

X is halogen.

2. A compound according to claim 1 having the structure:

wherein one or two G′ s are N, and the remaining G′ s are CH.

3. A compound according to claim 1 having the structure:

wherein:

one or both G′ s are N and, when only one G is N, the other G is CH, and b is 0-2.

4. A compound according to claim 1 wherein A is unsubstituted imidazolyl.

5. A compound according to claim 1 wherein A is a substituted imidazolyl.

6. A compound according to claim 5 wherein A is a 4-substituted imidazolyl.

7. A compound according to claim 5 wherein said imidazolyl is alkyl substituted.

8. A compound according to claim 5 wherein said imidazolyl is C 1 -C 5 alkyl substituted.

9. A compound according to claim 8 wherein said imidazolyl is methyl substituted.

10. A compound according to claim 8 wherein said imidazolyl is ethyl substituted.

11. A compound according to claim 5 wherein said imidazolyl is halogen substituted.

12. A compound according to claim 11 wherein said imidazolyl is chloro-substituted.

13. A compound according to claim 11 wherein said imidazolyl is bromo-substituted.

14. A compound according to claim 1 wherein B is unsubstituted 2-pyridinyl.

15. A compound according to claim 1 wherein at least one R 2 is a halogen.

16. A compound according to claim 15 wherein said halogen is fluorine.

17. A compound according to claim 1 wherein at least one R 2 is optionally substituted alkoxy.

18. A compound according to claim 1 wherein each R is hydrogen.

19. A compound according to claim 1 wherein X is chlorine.

20. A compound according to claim 1 wherein X is bromine.

21. A compound according to claim 1 wherein X is iodine.

22. A compound according to claim 1 having a structure selected from the group consisting of:

23. A method of making a compound according to claim 1 , said method comprising:

contacting an acetylpyridinyl-boronic acid with an optionally substituted imidazole in a suitable solvent under conditions suitable to form an imidazolyl pyridyl ketone, and thereafter contacting said imidazolyl pyridyl ketone with bromine under conditions suitable to form a compound of Formula (I).

24. A method of making a compound according to claim 1 , said method comprising:

contacting a chloropyridinyl-alkanone with an optionally substituted imidazole in a suitable solvent under conditions suitable to form an imidazolyl pyridyl ketone, and thereafter

contacting said imidazolyl pyridyl ketone with bromine under conditions suitable to form a compound of Formula (I).

25. A method of making a compound according to claim 1 , said method comprising:

contacting a 3-fluoro, 4-chloropyridinyl-alkanone with an optionally substituted imidazole in a suitable solvent under conditions suitable to form an imidazolyl fluoro pyridyl ketone, and thereafter

contacting said imidazolyl fluoropyridyl ketone with bromine under conditions suitable to form a compound of Formula (I).

26. A compound according to claim 1 wherein at least one R is hydrogen.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 20, 2010
From: TORREYPINES THERAPEUTICS, INC.
To: NEUROGENETIC PHARMACEUTICALS, INC.
Reel/Frame 024411/0706 →